Related Experiment Video
Updated: May 8, 2026
11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Intravitreal functional plasminogen is elevated in central retinal vein occlusion
Thomas Bertelmann1, Stefan Mennel, Walter Sekundo
1Department of Ophthalmology, Philipps University, Marburg, Germany.
Ophthalmic Research
|August 17, 2013
Summary
Intravitreal plasminogen levels are significantly elevated in patients with central retinal vein occlusion (CRVO). This finding suggests that intravitreal tissue plasminogen activator could be a potential treatment for inducing posterior vitreous detachment in CRVO patients.
Area of Science:
- Ophthalmology
- Vitreoretinal Surgery
- Thrombosis
Background:
- Central retinal vein occlusion (CRVO) is a serious vascular condition affecting vision.
- The role of intravitreal plasminogen in CRVO pathogenesis is not fully understood.
- Understanding intravitreal molecular changes is crucial for developing targeted therapies.
Purpose of the Study:
- To quantify functional plasminogen levels in the vitreous of CRVO patients.
- To compare intravitreal plasminogen concentrations between CRVO patients and control subjects.
- To investigate the potential therapeutic implications of elevated plasminogen in CRVO.
Main Methods:
- Prospective case series involving 13 CRVO patients and 10 controls.
- Vitreous samples were obtained via pars plana vitrectomy.
- Functional plasminogen was measured using an ultrasensitive p-nitroanilide assay after streptokinase activation.
Main Results:
- Plasminogen was detected in all vitreous samples analyzed.
- CRVO patients showed significantly higher mean intravitreal plasminogen (2.19%N) compared to controls (0.20%N).
- The difference in plasminogen levels between groups was statistically significant (p < 0.001).
Conclusions:
- Elevated intravitreal plasminogen is a characteristic finding in recent-onset CRVO.
- Intravitreal administration of tissue plasminogen activator (tPA) may be a viable therapeutic strategy.
- tPA could potentially be used for enzymatic vitreolysis to manage CRVO complications.
